Zobrazeno 1 - 4
of 4
pro vyhledávání: '"F. Romero Iborra"'
Autor:
M. Real Panisello, E. Arroyo Domingo, I. Castillo Valero, M.I. Sánchez Casado, C. Hernández Prats, F. Romero Iborra
Publikováno v:
Farmacia Hospitalaria. 34:218-223
Objective: Lenalidomide (LDM) is an immunomodulatory and anti-angiogenic drug which has been shown to be effective in several haematological disorders (multiple myeloma [MM], myeloid metaplasia with myelofibrosis [MF] and myelodysplastic syndrome [MD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::160a654cd4b4354d372429b026dc258d
https://doi.org/10.1016/j.farma.2010.02.002
https://doi.org/10.1016/j.farma.2010.02.002
Autor:
E. Arroyo Domingo, I. Castillo Valero, M. Real Panisello, F. Romero Iborra, M.I. Sánchez Casado, C. Hernández Prats
Publikováno v:
Farmacia Hospitalaria (English Edition). 34:218-223
Objective Lenalidomide (LDM) is an immunomodulatory and anti-angiogenic drug which has been shown to be effective in several haematological disorders (multiple myeloma [MM], myeloid metaplasia with myelofibrosis [MF] and myelodysplastic syndrome [MDS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af5aaa5774cff173f13f9fcc74b7843e
https://doi.org/10.1016/s2173-5085(10)70015-0
https://doi.org/10.1016/s2173-5085(10)70015-0
Autor:
C, Hernández Prats, F, Romero Iborra, E, Arroyo Domingo, I, Castillo Valero, M, Real Panisello, M I, Sánchez Casado
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 34(5)
Lenalidomide (LDM) is an immunomodulatory and anti-angiogenic drug which has been shown to be effective in several haematological disorders (multiple myeloma [MM], myeloid metaplasia with myelofibrosis [MF] and myelodysplastic syndrome [MDS]). The ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a579fcd07d661873aceae4fa028296e3
https://pubmed.ncbi.nlm.nih.gov/20615740
https://pubmed.ncbi.nlm.nih.gov/20615740
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.